It is also likely that the delay of blood stage parasitemia by the RhCMV-based malaria vaccines described here was mediated by CD8+ T cells since post-challenge CD8+ T cell responses, but not CD4+ T cells, correlated with decreased parasitemia. The gene discussed is CD8A; the disease is parasitic infectious disease.